Supplementary Figure 9: AERSMine workflow to identify differential response to therapeutics in TNF-elevated patients.

Example workflow of a multidimensional cohort-based study enabled by AERSMine to identify candidate factors with potential to increase/decrease relative risks for anti-TNF -associated AEs in TNF-elevated disorders (by reporting frequency).